Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
11,819 results
- Tipifarnib in Treating Patients With Relapsed or Refractory Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Tipifarnib in Treating Patients With Relapsed or Refractory Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00082888).
- Tipranavir/Ritonavir Low Dose Pharmacokinetics in Treatment Naive Patients: Complete Statistical AnalysisIndependent statistical analysis of Tipranavir/Ritonavir Low Dose Pharmacokinetics in Treatment Naive Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00530920).
- TIPSIndependent statistical analysis of Study to Evaluate the Efficacy of Infliximab Induction Therapy for Patients With Palmoplantar Psoriasis (PPP)(Study P04555)(COMPLETED): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- TIRCON-EXTIndependent statistical analysis of Long-term Deferiprone Treatment in Patients With Pantothenate Kinase-Associated Neurodegeneration: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02174848).
- TISIndependent statistical analysis of Trial of Aeroquin Versus Tobramycin Inhalation Solution (TIS) in Cystic Fibrosis (CF) Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Tislelizumab in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Gastric, or Gastroesophageal Junction Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of Tislelizumab in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Gastric, or Gastroesophageal Junction Carcinoma: primary endpoint results, effect estimate with confidence…
- Tissue Penetration of Ceftolozane/Tazobactam in Diabetic Patients With Lower Limb Infections: Complete Statistical AnalysisIndependent statistical analysis of Tissue Penetration of Ceftolozane/Tazobactam in Diabetic Patients With Lower Limb Infections: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- TitAINIndependent statistical analysis of A Placebo-controlled Phase 2 Trial to Investigate the Safety and Efficacy of Secukinumab in Giant Cell Arteritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- TITANIndependent statistical analysis of Study to Assess Efficacy and Safety of Anti-von Willebrand Factor (vWF) Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (aTTP): primary endpoint results, effect estimate with confidence interval,…
- TITREIndependent statistical analysis of Influenza Vaccine Dose-Response in Infants and Toddlers: Immunogenicity and Reactogenicity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00710866).
- TIVAIndependent statistical analysis of Targeting Inflammation to Treat Cardiovascular Aging: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01775865).
- Tivantinib in Treating Patients With Metastatic Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Tivantinib in Treating Patients With Metastatic Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01519414).
- TIVO-1Independent statistical analysis of A Study to Compare Tivozanib (AV-951) to Sorafenib in Subjects With Advanced Renal Cell Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- TK008Independent statistical analysis of Efficacy Study on the Strategy of HSV-Tk Engineering Donor Lymphocytes to Treat Patients With High Risk Acute Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- TKAIndependent statistical analysis of Dose-Ranging Study for Prolonged Postoperative Analgesia in Subject Undergoing Total Knee Arthroplasty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- TL011 in Severe, Active Rheumatoid Arthritis Patients: Complete Statistical AnalysisIndependent statistical analysis of TL011 in Severe, Active Rheumatoid Arthritis Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01123070).
- TMC114IFD3001 – Study Providing Continued Access to Treatment With Darunavir (DRV)/Ritonavir(Rtv) in HIV1 Infected Adults, Adolescents and Children Aged 3 Years or Above and Coming From Previous Company Sponsored Studies With DRV: Complete Statistical AnalysisIndependent statistical analysis of TMC114IFD3001 - Study Providing Continued Access to Treatment With Darunavir (DRV)/Ritonavir(Rtv) in HIV1 Infected Adults, Adolescents and Children Aged 3 Years or Above and Coming From Previous Company…
- TMC278LAIndependent statistical analysis of Phase II Safety and Acceptability of an Investigational Injectable Product, TMC278LA, for Pre-Exposure Prophylaxis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- TMDPACTIndependent statistical analysis of Tailored Self-Management of Temporomandibular Disorders (TMD) Using Health Information Technology: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03036215).
- TMS_AUD+mTBIIndependent statistical analysis of Pilot rTMS for AUD+mTBI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03995173).
- TMS4SIIndependent statistical analysis of TMS for Suicidal Crisis in Active Duty SMs: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03014362).
- TMSOCDIndependent statistical analysis of Transcranial Magnetic Stimulation (TMS) in Obsessive Compulsive Disorder (OCD): Mechanisms and Biomarkers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- TMZ + Olaparib for MGMT Hypermethylated Colorectal Cancer: Complete Statistical AnalysisIndependent statistical analysis of TMZ + Olaparib for MGMT Hypermethylated Colorectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04166435).
- TN05Independent statistical analysis of Rituximab in New Onset Type 1 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00279305).
- TN07Independent statistical analysis of Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- TNBCIndependent statistical analysis of Efficacy Study of MCS110 Given With Carboplatin and Gemcitabine in Advanced Triple Negative Breast Cancer (TNBC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- TNT-RASPIndependent statistical analysis of Topical Nitroglycerine Treatment for Radial Artery Spasm Prevention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02832115).
- To Assess Safety, Tolerability and Pharmacokinetics of BI 416970 in Healthy Male Volunteers: Complete Statistical AnalysisIndependent statistical analysis of To Assess Safety, Tolerability and Pharmacokinetics of BI 416970 in Healthy Male Volunteers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- To Assess the Efficacy and Safety of Intravitreal Ranibizumab in People With Vision Loss Due to Macular Edema: Complete Statistical AnalysisIndependent statistical analysis of To Assess the Efficacy and Safety of Intravitreal Ranibizumab in People With Vision Loss Due to Macular Edema: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- To Assess The Efficacy and Safety Of Oral Sildenafil in the Treatment of Pulmonary Arterial Hypertension.: Complete Statistical AnalysisIndependent statistical analysis of To Assess The Efficacy and Safety Of Oral Sildenafil in the Treatment of Pulmonary Arterial Hypertension.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- To Assess the Impact of Ferric Carboxymaltose Compared With Iron Sucrose in Chinese Subjects on Correcting Iron Deficiency Anaemia: Complete Statistical AnalysisIndependent statistical analysis of To Assess the Impact of Ferric Carboxymaltose Compared With Iron Sucrose in Chinese Subjects on Correcting Iron Deficiency Anaemia: primary endpoint results, effect estimate with confidence interval, sample-size…
- To Assess the Mildness of a Cosmetic Cleanser in Healthy Participants Using the Forearm-Controlled Application Technique (FCAT): Complete Statistical AnalysisIndependent statistical analysis of To Assess the Mildness of a Cosmetic Cleanser in Healthy Participants Using the Forearm-Controlled Application Technique (FCAT): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- To Compare Safety and Efficacy of Perrigo’s Drug Compared to an FDA Approved Drug in the Treatment of Actinic Keratosis: Complete Statistical AnalysisIndependent statistical analysis of To Compare Safety and Efficacy of Perrigo's Drug Compared to an FDA Approved Drug in the Treatment of Actinic Keratosis: primary endpoint results, effect estimate with confidence interval,…
- To Compare Safety and Efficacy of Perrigo’s Drug Product Compared to an FDA Approved Drug Product in the Treatment of Actinic Keratosis: Complete Statistical AnalysisIndependent statistical analysis of To Compare Safety and Efficacy of Perrigo's Drug Product Compared to an FDA Approved Drug Product in the Treatment of Actinic Keratosis: primary endpoint results, effect estimate with…
- To Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel of CHL Versus DUAC® Gel: Complete Statistical AnalysisIndependent statistical analysis of To Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel of CHL Versus DUAC® Gel: primary endpoint results, effect estimate with confidence interval,…
- To Compare the PK and Safety of Omalizumab (CT-P39, EU-approved Xolair, and US-licensed Xolair) in Healthy Subjects: Complete Statistical AnalysisIndependent statistical analysis of To Compare the PK and Safety of Omalizumab (CT-P39, EU-approved Xolair, and US-licensed Xolair) in Healthy Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- To Compare the Safety and Efficacy of Perrigo’s Product to an FDA Approved Product for the Treatment of Secondarily Infected Traumatic Skin Lesions: Complete Statistical AnalysisIndependent statistical analysis of To Compare the Safety and Efficacy of Perrigo's Product to an FDA Approved Product for the Treatment of Secondarily Infected Traumatic Skin Lesions: primary endpoint results, effect estimate…
- To Demonstrate Equivalent Pharmacokinetic Properties of HD204 and Bevacizumab (Avastin®) in Healthy Male Subjects: Complete Statistical AnalysisIndependent statistical analysis of To Demonstrate Equivalent Pharmacokinetic Properties of HD204 and Bevacizumab (Avastin®) in Healthy Male Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- To Demonstrate Similarity of Pharmacokinetics and Evaluate Safety of CT-P16, EU-Approved Avastin and US-licensed Avastin: Complete Statistical AnalysisIndependent statistical analysis of To Demonstrate Similarity of Pharmacokinetics and Evaluate Safety of CT-P16, EU-Approved Avastin and US-licensed Avastin: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- To Evaluate Efficacy, Safety, Tolerability and PK of Intravenous Cipargamin in Participants With Severe Plasmodium Falciparum Malaria: Complete Statistical AnalysisIndependent statistical analysis of To Evaluate Efficacy, Safety, Tolerability and PK of Intravenous Cipargamin in Participants With Severe Plasmodium Falciparum Malaria: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- To Evaluate The Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures: Complete Statistical AnalysisIndependent statistical analysis of To Evaluate The Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures: primary endpoint results, effect estimate with confidence interval, sample-size…
- To Evaluate the Efficacy of Eleutherococcus Senticosus for Subjects Under Renal Dialysis: Complete Statistical AnalysisIndependent statistical analysis of To Evaluate the Efficacy of Eleutherococcus Senticosus for Subjects Under Renal Dialysis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- To Evaluate the Safety and Efficacy of the Saline-coupled Bipolar Sealer in Primary Unilateral Total Knee Arthroplasty: Complete Statistical AnalysisIndependent statistical analysis of To Evaluate the Safety and Efficacy of the Saline-coupled Bipolar Sealer in Primary Unilateral Total Knee Arthroplasty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- To Evaluate the Safety, Tolerability, and Efficacy of TMC207 as Part of an Individualized Multi-drug Resistant Tuberculosis (MDR-TB) Treatment Regimen in Participants With Sputum Smear-positive Pulmonary MDR-TB.: Complete Statistical AnalysisIndependent statistical analysis of To Evaluate the Safety, Tolerability, and Efficacy of TMC207 as Part of an Individualized Multi-drug Resistant Tuberculosis (MDR-TB) Treatment Regimen in Participants With Sputum Smear-positive Pulmonary MDR-TB.: primary…
- To Investigate the Effects of Altering the Time of Day of Dosing (Morning or Evening) With Fluticasone Furoate 100 Micrograms Once Daily Administered Via a Dry Powder Inhaler in Subjects With Asthma: Complete Statistical AnalysisIndependent statistical analysis of To Investigate the Effects of Altering the Time of Day of Dosing (Morning or Evening) With Fluticasone Furoate 100 Micrograms Once Daily Administered Via a Dry Powder Inhaler…
- To Investigate the Efficacy of an Occluding Dentifrice in Dentinal Hypersensitivity (DH): Complete Statistical AnalysisIndependent statistical analysis of To Investigate the Efficacy of an Occluding Dentifrice in Dentinal Hypersensitivity (DH): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- To Investigate the Gastrointestinal Behaviour of Two Triple Combination Products in Healthy Male Volunteers: Complete Statistical AnalysisIndependent statistical analysis of To Investigate the Gastrointestinal Behaviour of Two Triple Combination Products in Healthy Male Volunteers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- To Investigate the Relative Efficacy of Terbutaline Turbuhaler® and Salbutamol Pressurized Metered Dose Inhaler (pMDI) a Single Blind Study: Complete Statistical AnalysisIndependent statistical analysis of To Investigate the Relative Efficacy of Terbutaline Turbuhaler® and Salbutamol Pressurized Metered Dose Inhaler (pMDI) a Single Blind Study: primary endpoint results, effect estimate with confidence interval, sample-size…
- To Measure Pain Perception Following De-Epithelized Free Gingival Graft Harvesting: Complete Statistical AnalysisIndependent statistical analysis of To Measure Pain Perception Following De-Epithelized Free Gingival Graft Harvesting: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03895476).
- To Measure Pain Perception With Electronic Pressure Algometer of Different Size Probes : a Healthy Subjects Research: Complete Statistical AnalysisIndependent statistical analysis of To Measure Pain Perception With Electronic Pressure Algometer of Different Size Probes : a Healthy Subjects Research: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…